Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Secondary Progressive Multiple Sclerosis (Phase II, Placebo-Controlled)
2006-006347-31Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in secondary-progressive multiple sclerosis (SPMS) comparing Simvastatin 80 mg with Placebo (2 arms). Primary endpoint: Annual percentage brain volume loss. Started Aug 2007; status: completed.
02
Drugs
simvastatin
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2006-006347-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006347-31.